Medication info
Glopozone 10/160 mg

Glopozone 10/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Keeps Biopharma Co., Ltd.
Appearance
Bright yellow, oval-shaped film-coated tablet
Packaging
28 tablets (14 tablets in PTP packaging x 2)
Approval status
Active

MFDS item code 201404978 · Approved 2014.10.28 · Insurance code 693201180

Summary

Main use
Treatment of essential hypertension inadequately controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. • 5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. • 5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. • 10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this drug to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Exercise caution when increasing the dose.
Child dose
The administration of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Keeps Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with monotherapy

  • Essential hypertension
View approved original text

In patients with essential hypertension where blood pressure control is insufficient with either Amlodipine or Valsartan alone, this medication helps effectively manage blood pressure by using both medications together. This contributes to stable blood pressure reduction and reduces the risk of cardiovascular diseases. This drug is used in the treatment of hypertension.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. • 5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. • 5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. • 10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this drug to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Exercise caution when increasing the dose.

Child dose

The administration of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals allergic to its active ingredients or similar classes of drugs, pregnant or breastfeeding women, patients with severe renal or hepatic impairment, and those with a history of certain heart diseases or angioedema. Patients with low sodium or fluid levels may experience hypotension, so their condition should be improved before use, and blood pressure should be monitored carefully after taking it. Patients with high potassium levels or who are taking medications that can increase potassium levels should frequently check their potassium levels. Patients with weak kidney function, kidney transplant recipients, or a history of angioedema need special caution when taking this medication, and should discontinue use immediately if symptoms appear. Patients with heart failure or after myocardial infarction should carefully observe changes in kidney function, and use should be cautious in some heart disease patients. Overdosage of this medication can cause hypotension, dizziness, and in severe cases, shock; thus, immediate medical attention is needed if overdosed. Dizziness or fatigue may occur while driving or operating machinery during treatment with this medication, so caution is advised. This medication may interact with other antihypertensive drugs, potassium supplements, or certain anti-inflammatory drugs, so it is crucial to inform healthcare providers of any other medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are advised to avoid it as well. The safety and efficacy of this drug in children under 18 years of age have not been established, thus its use is not recommended. Elderly patients may generally use the same dose as adults, but should consult with healthcare providers depending on their condition.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, itching, joint swelling, lumbago, arthritis, muscle cramps, fatigue, polyuria, nocturia, erectile dysfunction, edema, angioedema, facial swelling, peripheral edema, tiredness, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorders, peripheral neuropathy, idiopathic muscle hypertrophy, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, arthralgia, musculoskeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Also, it should be kept at room temperature between 1 to 30 degrees Celsius, avoiding extremely hot or cold environments.

Appearance and packaging

Appearance

Bright yellow, oval-shaped film-coated tablet

Package unit

28 tablets (14 tablets in PTP packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.